About: Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study
Creator	Tan, Ming Rose, Keith Perlin, David Sperber, Steven Park, Steven Siegel, David Balani, Bindu Brown, Emily Leslie, Lori Biran, Noa Cicogna, Cristina Goldberg, Stuart Goy, Andre Go, Ronaldo Ip, Andrew Pecora, Andrew Sebti, Rani Timmapuri, Sarah Al-Khan, Abdulla Arad, Danit Baker, Melissa Boonstra, Michele Buttner, Kathryn Chow, Kar Desai, Samit Donato, Michele Fanning, Stacey Feinman, Rena Feldman, Tatyana Geng, Xue Gillio, Alfred Gutierrez, Martin Kaur, Sukhdeep Kemp, Marlo Korngold, Robert Long, Laura Mckiernan, Phyllis Morawski, Alison Richards, Ernest Ricourt, Andrea Rowley, Scott Sadikot, Sean Singer, Sam Suh, Hyung Tam, Elizabeth Ullrich, Anna Vendivil, Mariefel Zenreich, Joshua
source	MedRxiv
abstract	Background Effective antiviral therapy against the severe acute respiratory syndrome virus 2 (SARS-CoV-2) remains elusive. Convalescent plasma is an anti-viral approach currently under investigation. We aimed to assess the laboratory and clinical parameters of patients with COVID-19 pneumonia treated with convalescent plasma containing high levels of neutralizing anti-SARS-CoV-2 antibodies.
has issue date	2020-07-26(xsd:dateTime)
bibo:doi	10.1101/2020.07.20.20156398
has license	medrxiv
sha1sum (hex)	f4f1af197676fb1446ab24311143d2846602fda9
schema:url	https://doi.org/10.1101/2020.07.20.20156398
resource representing a document's title	Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study
resource representing a document's body	covid:f4f1af197676fb1446ab24311143d2846602fda9#body_text
is schema:about of	named entity 'anti-viral' named entity 'convalescent' named entity 'ANTIVIRAL THERAPY' named entity 'LEVELS' named entity 'COVID-19 PNEUMONIA' covid:arg/f4f1af197676fb1446ab24311143d2846602fda9 named entity 'levels' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'severe acute respiratory syndrome virus' named entity 'titer' named entity 'randomized study' named entity 'invasive mechanical ventilation' named entity 'false discovery rate' named entity 'endogenous' named entity 'convalescent plasma' named entity 'intubation' named entity 'infusion' named entity 'endotracheal tube' named entity 'titer' named entity 'rash' named entity 'titer' named entity 'COVID' named entity '95% CI' named entity 'SARS-CoV-2' named entity 'immunocompromised patients' named entity 'pneumonia' named entity 'statistically significant' named entity 'COVID-19 disease' named entity 'viral titers' named entity 'intubation' named entity 't-test' named entity 'inflammatory markers' named entity 'cancer center' named entity 'symptom' named entity 'non-invasive positive pressure ventilation' named entity 'lymphoma'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software